RET-positive Non-small Cell Lung Cancer (NSCLC)
1 clinical trials · Condition
◉ Watch RET-positive Non-small Cell Lung Cancer (NSCLC)
| Record | Firm | Date |
|---|---|---|
| A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer (NCT03131206) | Dana-Farber Cancer Institute | 2017-06-19 |
Track RET-positive Non-small Cell Lung Cancer (NSCLC) automatically
Every clearance here is in the API, with alerts when new ones post.